CD5 POSITIVE

Clinical trials for CD5 POSITIVE explained in plain language.

Never miss a new study

Get alerted when new CD5 POSITIVE trials appear

Sign up with your email to follow new studies for CD5 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

Hope for Hard-to-Treat lymphoma: Anti-Inflammatory drug joins chemo in new trial

Disease control Not yet recruiting

This study tests whether adding the anti-inflammatory drug celecoxib to standard chemotherapy (R-CHOP) works better than chemotherapy alone for people with a specific, aggressive type of lymphoma called CD5-positive diffuse large B-cell lymphoma. About 60 adults with newly diagno…

Matched conditions: CD5 POSITIVE

Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Jun 15, 2026 19:05 UTC

CD5 POSITIVE

Get alerted when new CD5 POSITIVE trials appear

Hope for Hard-to-Treat lymphoma: Anti-Inflammatory drug joins chemo in new trial